Severe Dengue with Hepatorenal Dysfunction
Abstract
We present the case of a 50-year-old male patient, previously healthy, residing in an endemic area, who presented with a febrile disease, headache, and myalgias. Following self-medication and persistence of symptoms, he presented to the emergency department with vomiting and abdominal pain and was admitted to hospital. On the sixth day of evolution, he developed jaundice, dark urine, progressive oliguria, gingival bleeding, anuria, and deterioration of the consciousness level, for which he was transferred to the intensive care unit. Laboratory studies showed marked elevation of transaminases (AST 1460 U/L, ALT 930 U/L), creatinine of 6.4 mg/dL, thrombocytopenia (35 × 10⁹/L), and coagulopathy. Dengue serology was positive (NS1 and IgM). Abdominal ultrasonography revealed hepatomegaly, perivesicular edema, and bilateral pleural effusion. Management included hemodynamic support (norepinephrine), controlled hydration, fresh frozen plasma, and renal replacement therapy (3 hemodialysis sessions). After 15 days, vasopressor and renal support were discontinued with progressive improvement of hepatic and renal function. He was discharged on day 21 with normal renal function and hepatic enzymes near normal. This case underscores the possibility of severe multi-organ involvement in dengue and the importance of early multidisciplinary intensive management.
Downloads
References
1.Kantor IN. El dengue en Argentina y las estrategias actuales para su control. Medicina (B Aires). 2024 [citado 23/12/2025];84(4):787-90. Disponible en: https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802024000600787&lng=es
2.ChediaCk V, BlanCo M, Balasini C, Juárez P, González AL, et al. Dengue grave. Rev Argent Ter Intensiva. 2021 [citado 23/12/2025];38:e707. Disponible en: https://revista.sati.org.ar/index.php/MI/es/article/view/707/856
3.Pérez Díaz Y, Rodríguez Puga R, Peña López DM. El enfrentamiento al dengue como problema de salud desde el enfoque de ciencia, tecnología e innovación. Ciencia y Educación. 2025[citado 26/12/2025];6(8.1):119-31. Disponible en: https://www.cienciayeducacion.com/index.php/journal/article/view/zenodo.18238997/21854 4.Domínguez Rojas J, Cabrera Rojas L, Prado Gómez T, Atamari Anahui N. Falla hepática aguda fulminante secundario a dengue severo en un niño: reporte de un caso. Rev Gastroenterol Perú. 2024 [citado 24/12/2025];44(2):150-4. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292024000200150&lng=es
5.Chaviano Salgado O, Pérez de la Paz A. Complicaciones inusuales del dengue. Medicentro Electrónica. 2024 [citado 26/12/2025];28(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432024000100035&lng=es
6.Reyes Pérez MA, Calero Arcos JG, García Córdova MO, Lema Montes JD. Manifestaciones clínicas y curso evolutivo del dengue grave en poblaciones pediátricas y adultas. SRS. 2025 [citado 26/12/2025];3(especial):128-36. Disponible en: https://www.revistasinstitutoperspectivasglobales.org/index.php/sanitas/article/view/683/1381
7.Navas Castillo JS, Guzmán Torres M, Baldizón Pernillo DK, Orellana Pinto DF, Samayoa Bran AJ. Caracterización clínica de dengue con signos de alarma y dengue grave en adultos. Hospital Roosevelt, Guatemala. Anfamed. 2024 [citado 24/12/2025];11(2):e203. Disponible en: http://www.scielo.edu.uy/pdf/afm/v11n2/2301-1254-afm-11-02-e203.pdf
8.Cabezas C, Durand S. Estrategias integradas para el control del dengue en el Perú, ¿hay nuevas opciones? An Fac Med (Lima). 2024 [citado 23/12/2025];85(1):3-5. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832024000100001&lng=es
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Carlos Rafael Cabrera Pérez, Edilberto Fonseca Viñales

This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
